Meeting News

Pembrolizumab demonstrates antitumor activity in small cell lung cancer

August 16, 2018
CHICAGO — Pembrolizumab demonstrated “promising” antitumor activity among patients with advanced small-cell lung cancer…
Meeting News

Lymph node collection kit improves outcomes of lung cancer resection

August 15, 2018
CHICAGO — The use of a lymph node specimen collection kit during non-small cell lung cancer resection significantly improved staging quality…
Meeting News

Bevacizumab plus erlotinib improves PFS for non-small cell lung cancer

August 13, 2018
CHICAGO — Phase 3 data from the NEJ026 trial showed that a combination regimen of bevacizumab plus erlotinib prolonged PFS compared with…
Meeting News

Dacomitinib improves OS for EGFR-positive lung cancer, may be of limited clinical use

August 3, 2018
CHICAGO — Updated phase 3 data from the ARCHER 1050 trial showed that dacomitinib improved OS compared with gefitinib among patients with newly…
Meeting News

Novel tests show promise in early-stage lung cancer detection

August 2, 2018
CHICAGO — Three prototype sequencing assays designed to identify cancer-specific cell-free DNA signals were effective in detecting early-stage…
Meeting News

Steroids lower survival benefits associated with immune checkpoint inhibitors in lung cancer

July 10, 2018
CHICAGO — The use of steroids at baseline was associated with inferior survival outcomes in patients with advanced non-small cell lung cancer…
Meeting News

Pembrolizumab demonstrates survival benefit in some lung cancer patients

July 9, 2018
CHICAGO — First-line pembrolizumab conferred longer median OS than chemotherapy among patients with non-small cell lung cancer and PD-L1…
Meeting News

Atezolizumab plus chemotherapy improves survival in lung cancer subtype

June 28, 2018
CHICAGO — The addition of atezolizumab to bevacizumab plus chemotherapy extended OS for patients with non-small cell lung cancer, according to…
Meeting News

Low screening rates highlight a ‘major issue’ with lung cancer

June 27, 2018
CHICAGO —Less than 2% of the more than 7 million current and former heavy smokers eligible for lung cancer screening underwent screening at…
Meeting NewsVideo

VIDEO: Uncertain role for dacomitinib in current lung cancer landscape

June 25, 2018
CHICAGO — Dacomitinib improved OS compared with gefitinib among patients with newly diagnosed, advanced EGFR-positive non-small cell lung…